Sapient Discovery, LLC.

Sapient Discovery is a biotechnology company with high-end paltform for the discovery & optimization of molecules that can become therapeutics.

Sapient Discovery's expert team of computational chemists and structural biologists have a track record of successfully identifying lead molecules. Thus far, more than 35 different protein drug targets have been processed with their technology, comprising a diverse set of structural classes of proteins including enzymes, GPCRs, and protein-protein interaction targets. Some of these are in pre-clinical development, with at least one approved drug in EU the treatment of an important cardiovascular disease (pulmonary arterial hypertension). Sapient Discovery offers their platform for collaborative drug discovery with other companies and institutions.